Revolution Medicines (RVMD) Current Assets (2019 - 2026)

Revolution Medicines' Current Assets history runs 8 years deep, the most recent figure standing at $2.0 billion for Q1 2026.

• In Q1 2026, Current Assets fell 7.81% year-over-year to $2.0 billion; the TTM figure through Mar 2026 stood at $2.0 billion (down 7.81% YoY), while the FY2025 annual figure was $2.1 billion, down 10.85% from the prior year.
• Current Assets was $2.0 billion for Q1 2026 at Revolution Medicines, down from $2.1 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $2.3 billion in Q4 2024 to a low of $483.0 million in Q2 2022.
• Historically, Current Assets has averaged $1.4 billion across 5 years, with a median of $1.6 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Current Assets declined 26.92% in 2022, then jumped 184.66% in 2023.
• A 5-year view of Current Assets shows it stood at $660.2 million in 2022, then surged by 184.66% to $1.9 billion in 2023, then advanced by 23.86% to $2.3 billion in 2024, then declined by 10.85% to $2.1 billion in 2025, then retreated by 5.16% to $2.0 billion in 2026.
• The last three Current Assets figures came in at $2.0 billion (Q1 2026), $2.1 billion (Q4 2025), and $2.0 billion (Q3 2025), per Business Quant data.